Predictive models and correlates of protection for testing biodefence vaccines (Q37745002)

22 August 2017

1 reference

title

Predictive models and correlates of protection for testing biodefence vaccines (English)

1 reference

22 August 2017

E Diane Williamson

1

1 reference

22 August 2017

M G Duchars

series ordinal

2

1 reference

22 August 2017

Robert Kohberger

series ordinal

3

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Expert Review of Vaccines

22 August 2017

published in

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

527-537

1 reference

Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).

22 August 2017

cites work

1 reference

Animal models in influenza vaccine testing.

21 January 2018

1 reference

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

21 January 2018

1 reference

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax

21 January 2018

1 reference

Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species

21 January 2018

1 reference

Multiplex mapping of CD4 T cell epitopes using class II tetramers

21 January 2018

1 reference

T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice

21 January 2018

1 reference

Differential Processing of CD4 T-cell Epitopes from the Protective Antigen of Bacillus anthracis

21 January 2018

1 reference

Anti-immunoglobulin responses to IgG, F(ab')2, and Fab botulinum antitoxins in mice

21 January 2018

1 reference

Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection

21 January 2018

1 reference

Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality

21 January 2018

1 reference

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

21 January 2018

1 reference

Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax

21 January 2018

1 reference

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

The perfect mix: recent progress in adjuvant research

21 January 2018

1 reference

CpG-DNA protects against a lethal orthopoxvirus infection in a murine model

21 January 2018

1 reference

Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.

21 January 2018

1 reference

Anthrax toxin: receptor binding, internalization, pore formation, and translocation

21 January 2018

1 reference

Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways

21 January 2018

1 reference

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

21 January 2018

1 reference

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis

21 January 2018

1 reference

New horizons in adjuvants for vaccine development

21 January 2018

1 reference

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

21 January 2018

1 reference

Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides broad protection, in murine models, against airborne challenge with viruses from serogroups I, II and III.

21 January 2018

1 reference

Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus

21 January 2018

1 reference

Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice

21 January 2018

1 reference

Antibody and interleukin-12 treatment in murine models of encephalitogenic flavivirus (St. Louis encephalitis, tick-borne encephalitis) and alphavirus (Venezuelan equine encephalitis) infection

21 January 2018

1 reference

Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague

21 January 2018

1 reference

The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation

21 January 2018

1 reference

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles

21 January 2018

1 reference

Function and molecular architecture of the Yersinia injectisome tip complex

21 January 2018

1 reference

Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague

21 January 2018

1 reference

Yersinia pestis V protein epitopes recognized by CD4 T cells

21 January 2018

1 reference

Cell-mediated protection against pulmonary Yersinia pestis infection

21 January 2018

1 reference

Vaccines against Francisella tularensis

21 January 2018

1 reference

Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection

21 January 2018

1 reference

A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei

21 January 2018

1 reference

Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.

21 January 2018

1 reference

Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

21 January 2018

1 reference

Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei

21 January 2018

1 reference

Protective efficacy of a fully recombinant plague vaccine in the guinea pig.

21 January 2018

1 reference

CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

21 January 2018

1 reference

Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens

21 January 2018

1 reference

The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses

21 January 2018

1 reference

Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis

21 January 2018

1 reference

Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes

21 January 2018

1 reference

CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.

21 January 2018

1 reference

Evaluating a surrogate endpoint at three levels, with application to vaccine development

21 January 2018

1 reference

A framework for assessing immunological correlates of protection in vaccine trials

21 January 2018

1 reference

Prediction of pertussis vaccine efficacy using a correlates of protection model

21 January 2018

1 reference

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.22

1 reference

22 August 2017

1 reference